IL108623A0 - Silylated acetylcholinesterase inhibitors - Google Patents
Silylated acetylcholinesterase inhibitorsInfo
- Publication number
- IL108623A0 IL108623A0 IL10862394A IL10862394A IL108623A0 IL 108623 A0 IL108623 A0 IL 108623A0 IL 10862394 A IL10862394 A IL 10862394A IL 10862394 A IL10862394 A IL 10862394A IL 108623 A0 IL108623 A0 IL 108623A0
- Authority
- IL
- Israel
- Prior art keywords
- silylated
- acetylcholinesterase inhibitors
- compounds
- methods
- acetylcholinesterase
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93400385A EP0611769A1 (de) | 1993-02-16 | 1993-02-16 | Silytierte acetylcholinesterase Inhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL108623A0 true IL108623A0 (en) | 1994-05-30 |
Family
ID=8214682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10862394A IL108623A0 (en) | 1993-02-16 | 1994-02-11 | Silylated acetylcholinesterase inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP0611769A1 (de) |
| JP (1) | JP3516955B2 (de) |
| KR (1) | KR100336547B1 (de) |
| CN (1) | CN1043575C (de) |
| AT (1) | ATE152725T1 (de) |
| AU (1) | AU672885B2 (de) |
| CA (1) | CA2154870C (de) |
| DE (1) | DE69403068T2 (de) |
| DK (1) | DK0684951T3 (de) |
| ES (1) | ES2104358T3 (de) |
| FI (1) | FI111461B (de) |
| GR (1) | GR3024151T3 (de) |
| HU (1) | HUT72736A (de) |
| IL (1) | IL108623A0 (de) |
| MX (1) | MX9401175A (de) |
| NO (1) | NO305517B1 (de) |
| NZ (1) | NZ262247A (de) |
| WO (1) | WO1994019356A1 (de) |
| ZA (1) | ZA94925B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0627400A1 (de) * | 1993-06-04 | 1994-12-07 | Merrell Dow Pharmaceuticals Inc. | Aromatische Inhibitoren von Acetylcholinesterase |
| CN100431539C (zh) * | 2004-01-12 | 2008-11-12 | 和泓生物技术（上海）有限公司 | 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用 |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| NZ579310A (en) | 2007-03-01 | 2012-03-30 | Probiodrug Ag | Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof |
| DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
| US8486940B2 (en) | 2009-09-11 | 2013-07-16 | Probiodrug Ag | Inhibitors |
| CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
| EP2542549B1 (de) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Glutaminylcyclase-hemmer |
| BR112012022478B1 (pt) | 2010-03-10 | 2021-09-21 | Probiodrug Ag | Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| EP3827820A1 (de) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam zur verbesserung der kognitiven funktion |
| BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| CN112047973B (zh) * | 2019-06-06 | 2022-11-18 | 上海科技大学 | 一种大麻素类化合物，其制备方法、组合物和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0403713A1 (de) * | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Acetylcholinesterase-Inhibitoren |
-
1993
- 1993-02-16 EP EP93400385A patent/EP0611769A1/de not_active Withdrawn
-
1994
- 1994-01-25 HU HU9502406A patent/HUT72736A/hu unknown
- 1994-01-25 ES ES94908615T patent/ES2104358T3/es not_active Expired - Lifetime
- 1994-01-25 EP EP94908615A patent/EP0684951B1/de not_active Expired - Lifetime
- 1994-01-25 DK DK94908615.1T patent/DK0684951T3/da active
- 1994-01-25 CN CN94191196A patent/CN1043575C/zh not_active Expired - Fee Related
- 1994-01-25 WO PCT/US1994/000720 patent/WO1994019356A1/en active IP Right Grant
- 1994-01-25 CA CA002154870A patent/CA2154870C/en not_active Expired - Fee Related
- 1994-01-25 DE DE69403068T patent/DE69403068T2/de not_active Expired - Lifetime
- 1994-01-25 NZ NZ262247A patent/NZ262247A/en unknown
- 1994-01-25 JP JP51897494A patent/JP3516955B2/ja not_active Expired - Fee Related
- 1994-01-25 AT AT94908615T patent/ATE152725T1/de active
- 1994-01-25 KR KR1019950703485A patent/KR100336547B1/ko not_active IP Right Cessation
- 1994-01-25 AU AU61641/94A patent/AU672885B2/en not_active Ceased
- 1994-02-10 ZA ZA94925A patent/ZA94925B/xx unknown
- 1994-02-11 IL IL10862394A patent/IL108623A0/xx unknown
- 1994-02-15 MX MX9401175A patent/MX9401175A/es not_active Application Discontinuation
-
1995
- 1995-08-15 FI FI953851A patent/FI111461B/fi not_active IP Right Cessation
- 1995-08-15 NO NO953201A patent/NO305517B1/no unknown
-
1997
- 1997-07-16 GR GR970401801T patent/GR3024151T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69403068D1 (en) | 1997-06-12 |
| KR100336547B1 (ko) | 2002-11-02 |
| ATE152725T1 (de) | 1997-05-15 |
| AU6164194A (en) | 1994-09-14 |
| EP0611769A1 (de) | 1994-08-24 |
| AU672885B2 (en) | 1996-10-17 |
| NZ262247A (en) | 1996-01-26 |
| JP3516955B2 (ja) | 2004-04-05 |
| CN1043575C (zh) | 1999-06-09 |
| DE69403068T2 (de) | 1997-12-11 |
| ES2104358T3 (es) | 1997-10-01 |
| GR3024151T3 (en) | 1997-10-31 |
| EP0684951A1 (de) | 1995-12-06 |
| MX9401175A (es) | 1994-08-31 |
| JPH08507059A (ja) | 1996-07-30 |
| WO1994019356A1 (en) | 1994-09-01 |
| DK0684951T3 (da) | 1997-05-26 |
| EP0684951B1 (de) | 1997-05-07 |
| CA2154870A1 (en) | 1994-09-01 |
| FI953851A0 (fi) | 1995-08-15 |
| FI111461B (fi) | 2003-07-31 |
| NO305517B1 (no) | 1999-06-14 |
| KR960701068A (ko) | 1996-02-24 |
| HUT72736A (en) | 1996-05-28 |
| NO953201L (no) | 1995-08-15 |
| ZA94925B (en) | 1994-08-25 |
| NO953201D0 (no) | 1995-08-15 |
| FI953851A (fi) | 1995-08-15 |
| CN1117733A (zh) | 1996-02-28 |
| CA2154870C (en) | 1998-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL109863A0 (en) | Aromatic acetylcholinesterase inhibitors | |
| ZA94925B (en) | Silylated acetylcholinesterase inhibitors | |
| HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
| HU9500933D0 (en) | Use of il-10 to prevent or treat insulin-dependent diabetes mellitus | |
| EP0630383A4 (de) | Methoden zur behandlung von diabetis. | |
| EP0710106A4 (de) | Verfahren zur behandlung von suchtverhalten | |
| HU9301169D0 (en) | Method for improving flame-proofness of plastics by means of addition of guanidine-barbiturates and/or guanidine-thiobarbiturates as burning inhibitors, flame-proof plastics containing said compounds as well as these compounds | |
| ZA912236B (en) | Hydroxymethyl-indolizidines and quinolizidines | |
| GB9317943D0 (en) | Treatment of laminitis | |
| EP0654996A4 (de) | Verfahren zur behandlung von psoriasis unter anwendung von substituierten azaspiranen. | |
| GB9317989D0 (en) | Treatment of laminitis | |
| HU9301187D0 (en) | Method for treating tumours being dependent of gar-transformylase | |
| GB9217355D0 (en) | Treating hides | |
| EP0608702A3 (de) | Verfahren zum Behandeln von Haselnüssen. | |
| EP0932406A4 (de) | Verfahren zur behandlung oder vorbeugung der interstitiellen blasenentzündung | |
| EP0654997A4 (de) | Zusammensetzungen von substituierten azaspiranen und verfahren zur behandlung von psoriasis damit. | |
| GB9314466D0 (en) | Methods of treating diamonds | |
| GB9308853D0 (en) | Novel method of treatment |